塔苏斯制药公司
US ˙ NasdaqGS ˙ US87650L1035

介绍

本页面提供了有关 Azamian Bobak R. 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Azamian Bobak R.已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:TARS / Tarsus Pharmaceuticals, Inc. President/CEO and Board Chair, Director 818,106
如何解读这些图表

以下图表显示了在Azamian Bobak R.进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

TARS / Tarsus Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 TARS / Tarsus Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
TARS / Tarsus Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 TARS / Tarsus Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2025-03-20 TARS Azamian Bobak R. 8,534 50.1100 8,534 50.1100 427,639 133 38.8200 -96,348 -22.53
2025-03-19 TARS Azamian Bobak R. 8,551 47.4000 8,551 47.4000 405,317
2025-03-18 TARS Azamian Bobak R. 7,131 46.2900 7,131 46.2900 330,094
2024-03-18 TARS Azamian Bobak R. 10,415 30.6000 10,415 30.6000 318,699
2023-03-23 TARS Azamian Bobak R. 737 12.1500 737 12.1500 8,955
2023-03-22 TARS Azamian Bobak R. 709 12.6400 709 12.6400 8,962
2023-03-21 TARS Azamian Bobak R. 679 12.8900 679 12.8900 8,752
2023-03-20 TARS Azamian Bobak R. 741 12.6100 741 12.6100 9,344
2023-03-17 TARS Azamian Bobak R. 795 13.2800 795 13.2800 10,558
2023-03-16 TARS Azamian Bobak R. 791 13.4300 791 13.4300 10,623

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
内幕交易历史

该表格显示了由 Azamian Bobak R. 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2025-08-13 2025-08-11 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,000 818,106 -0.73 50.00 -300,000 40,905,300
2025-03-26 2025-03-24 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,000 824,106 -0.72 50.00 -300,000 41,205,300
2025-03-20 2025-03-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -8,534 53,635 -13.73 50.11 -427,639 2,687,650
2025-03-20 2025-03-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -8,551 62,169 -12.09 47.40 -405,317 2,946,811
2025-03-20 2025-03-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -7,131 70,720 -9.16 46.29 -330,094 3,273,629
2025-03-18 2025-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		M - Exercise 51,395 77,851 194.27
2024-03-19 2024-03-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -10,415 26,456 -28.25 30.60 -318,699 809,554
2024-03-19 2024-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		M - Exercise 28,274 36,871 328.88
2023-12-29 2023-12-27 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 830,106 -0.95 20.22 -161,760 16,784,743
2023-12-22 2023-12-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -30,557 838,106 -3.52 20.36 -622,141 17,063,838
2023-12-22 2023-12-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,443 868,663 -1.08 19.96 -188,482 17,338,513
2023-11-17 2023-11-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -200 878,106 -0.02 19.28 -3,856 16,929,884
2023-11-17 2023-11-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,904 878,306 -0.56 18.54 -90,920 16,283,793
2023-11-17 2023-11-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,896 883,210 -0.33 18.01 -52,157 15,906,612
2023-10-20 2023-10-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 886,106 -0.89 13.24 -105,920 11,732,043
2023-09-22 2023-09-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 894,106 -0.89 17.21 -137,680 15,387,564
2023-08-25 2023-08-23 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 902,106 -0.88 17.23 -137,840 15,543,286
2023-07-21 2023-07-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -99,726 910,106 -9.88 20.04 -1,998,509 18,238,524
2023-07-21 2023-07-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,174 1,009,832 -0.41 19.28 -80,475 19,469,561
2023-07-14 2023-07-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,000 1,014,006 -0.88 17.35 -156,150 17,593,004
2023-06-23 2023-06-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,023,006 -0.78 18.63 -149,040 19,058,602
2023-06-16 2023-06-14 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,000 1,031,006 -0.87 18.58 -167,220 19,156,091
2023-06-12 2023-06-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,100 1,040,006 -0.30 20.01 -62,031 20,810,520
2023-05-19 2023-05-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,043,106 -0.76 15.90 -127,200 16,585,385
2023-05-12 2023-05-10 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,000 1,051,106 -0.85 16.80 -151,200 17,658,581
2023-05-02 2023-05-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,841 1,060,106 -0.55 15.10 -88,199 16,007,601
2023-05-02 2023-04-28 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,278 1,065,947 -0.40 15.13 -64,726 16,127,778
2023-04-25 2023-04-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,311 1,070,225 -0.22 15.03 -34,734 16,085,482
2023-04-21 2023-04-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,072,536 -0.74 13.60 -108,800 14,586,490
2023-03-23 2023-03-23 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -737 8,597 -7.90 12.15 -8,955 104,454
2023-03-23 2023-03-22 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -709 9,334 -7.06 12.64 -8,962 117,982
2023-03-23 2023-03-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -679 10,043 -6.33 12.89 -8,752 129,454
2023-03-21 2023-03-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -741 10,722 -6.46 12.61 -9,344 135,204
2023-03-21 2023-03-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -795 11,463 -6.49 13.28 -10,558 152,229
2023-03-17 2023-03-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale -791 12,258 -6.06 13.43 -10,623 164,625
2023-03-17 2023-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		M - Exercise 11,299 13,049 645.66
2023-03-17 2023-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,080,536 -0.73 13.79 -110,320 14,900,591
2023-03-10 2023-03-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -717 1,088,536 -0.07 15.01 -10,762 16,338,925
2023-03-10 2023-03-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,853 1,089,253 -0.44 15.02 -72,892 16,360,580
2023-02-17 2023-02-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,094,106 -0.73 15.28 -122,240 16,717,940
2023-02-10 2023-02-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,000 1,102,106 -0.81 15.14 -136,260 16,685,885
2023-01-25 2023-01-23 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,856 1,111,106 -0.44 15.45 -75,025 17,166,588
2023-01-24 2023-01-06 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -411 1,129,740 -0.04 15.00 -6,165 16,946,100
2023-01-20 2023-01-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -240 1,116,373 -0.02 15.00 -3,600 16,745,595
2023-01-20 2023-01-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,116,613 -0.71 14.56 -116,480 16,257,885
2023-01-13 2023-01-11 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,904 1,124,613 -0.35 15.11 -58,989 16,992,902
2023-01-11 2023-01-10 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -905 1,128,517 -0.08 15.17 -13,729 17,119,603
2023-01-11 2023-01-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -729 1,129,422 -0.06 15.15 -11,044 17,110,743
2022-12-22 2022-12-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 1,130,151 -0.70 14.57 -116,560 16,466,300
2022-12-20 2022-12-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -535 1,138,151 -0.05 15.01 -8,030 17,083,647
2022-12-16 2022-12-14 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,420 1,138,686 -0.56 15.08 -96,814 17,171,385
2022-11-18 2022-11-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -745 1,145,106 -0.07 17.31 -12,896 19,821,785
2022-11-18 2022-11-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,255 1,145,851 -0.63 16.81 -121,957 19,261,755
2022-11-14 2022-11-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,000 1,153,106 -0.77 17.87 -160,830 20,606,004
2022-10-21 2022-10-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 1,162,106 -0.01 17.60 -1,760 20,453,066
2022-10-21 2022-10-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,900 1,162,206 -0.68 16.91 -133,589 19,652,903
2022-10-14 2022-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,821 1,170,106 -0.24 16.24 -45,813 19,002,521
2022-10-14 2022-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,179 1,172,927 -0.52 15.76 -97,381 18,485,330
2022-09-23 2022-09-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 1,179,106 -0.01 17.04 -1,704 20,097,862
2022-09-23 2022-09-21 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,900 1,179,206 -0.67 16.30 -128,770 19,221,058
2022-09-16 2022-09-14 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,000 1,187,106 -0.75 16.01 -144,090 19,005,567
2022-08-19 2022-08-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -736 1,196,106 -0.06 17.44 -12,836 20,860,089
2022-08-19 2022-08-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,264 1,196,842 -0.60 16.50 -119,856 19,747,893
2022-03-11 2022-03-09 4 TARS Tarsus Pharmaceuticals, Inc.
Restricted Stock Units 		A - Award 45,197 45,197
2022-03-11 2022-03-09 4 TARS Tarsus Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 154,067 154,067
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -578 1,204,106 -0.05 26.76 -15,467 32,221,877
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -760 1,204,684 -0.06 25.90 -19,684 31,201,316
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,101 1,205,444 -0.17 24.70 -51,895 29,774,467
2021-12-03 2021-12-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,394 1,207,545 -0.20 23.86 -57,121 28,812,024
2021-11-03 2021-11-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -800 1,209,939 -0.07 28.21 -22,568 34,132,379
2021-11-03 2021-11-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,033 1,210,739 -0.41 27.76 -139,716 33,610,115
2021-10-14 2021-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,698 1,215,772 -0.38 26.44 -124,215 32,145,012
2021-10-14 2021-10-12 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -833 1,220,470 -0.07 25.49 -21,233 31,109,780
2021-10-12 2021-10-08 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -302 1,221,303 -0.02 25.02 -7,555 30,554,558
2021-09-03 2021-09-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 1,221,605 -0.01 26.40 -2,640 32,250,372
2021-09-03 2021-09-01 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,733 1,221,705 -0.47 25.23 -144,661 30,827,282
2021-08-12 2021-08-11 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,917 1,227,438 -0.16 25.07 -48,061 30,773,098
2021-08-12 2021-08-10 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -103 1,229,355 -0.01 25.00 -2,575 30,733,875
2021-08-10 2021-08-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 1,229,458 -0.01 25.13 -2,513 30,896,280
2021-08-10 2021-08-09 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -727 1,229,558 -0.06 25.00 -18,175 30,738,950
2021-08-10 2021-08-06 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,616 1,230,285 -0.13 25.00 -40,400 30,757,125
2021-08-06 2021-08-05 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,370 1,231,901 -0.11 25.00 -34,250 30,797,525
2021-01-08 2021-01-07 4 TARS Tarsus Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 204,998 204,998
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Series B Preferred Stock 		C - Conversion -1,750 0 -100.00
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Series A Preferred Stock 		C - Conversion -21,575 0 -100.00
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		C - Conversion 1,750 1,750
2020-10-20 2020-10-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		C - Conversion 21,575 1,233,271 1.78
2020-10-15 3 TARS Tarsus Pharmaceuticals, Inc.
Common Stock 		1,211,696
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）